| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $35.2M | — | +2.1% |
| Cost of Revenue | $36.8M | — | +27.2% |
| Gross Profit | -$1.5M | — | -127.7% |
| R&D Expense | $7.5M | — | +85.9% |
| SG&A Expense | $31.4M | — | +19.3% |
| Operating Income | -$44.6M | — | -69.8% |
| Pre-tax Income | -$42.7M | — | -53.2% |
| Income Tax | $3.2M | — | +6620.8% |
| Net Income | -$44.0M | — | -63.3% |
| EPS (Basic) | -$0.75 | — | +67.4% |
| EPS (Diluted) | -$0.75 | — | +67.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $429.4M | -12.6% | — |
| Accounts Receivable | $12.2M | -59.2% | — |
| Inventory | $5.7M | +49.5% | — |
| Current Assets | $508.7M | -12.5% | — |
| Total Assets | $1.02B | -2.5% | — |
| Current Liabilities | $111.3M | -16.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$39.7M | — | -176.7% |
| Capital Expenditures | $51.1M | — | +89.5% |
| Investing Cash Flow | -$32.9M | — | -267.0% |
| Financing Cash Flow | $10.7M | — | -92.5% |
| Free Cash Flow | -$90.8M | — | -119.8% |
| Total Liabilities | $619.2M | -0.3% | — |
| Stockholders' Equity | $357.2M | -6.9% | +616.9% |